Cue Biopharma, Inc. (CUE)
18.65
+0.20
(+1.08%)
USD |
NASDAQ |
Oct 27, 14:36
Cue Biopharma Total Return Level : 18.45 for Oct. 26, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 26, 2026 | 18.45 |
| October 23, 2026 | 18.66 |
| October 22, 2026 | 18.89 |
| October 21, 2026 | 18.95 |
| October 20, 2026 | 17.04 |
| October 19, 2026 | 16.08 |
| October 16, 2026 | 16.71 |
| October 15, 2026 | 18.67 |
| October 14, 2026 | 18.60 |
| October 13, 2026 | 19.57 |
| October 12, 2026 | 24.61 |
| October 09, 2026 | 27.66 |
| October 08, 2026 | 22.33 |
| October 07, 2026 | 22.51 |
| October 06, 2026 | 23.14 |
| October 05, 2026 | 24.36 |
| October 02, 2026 | 25.57 |
| October 01, 2026 | 25.25 |
| September 30, 2026 | 25.87 |
| September 29, 2026 | 25.51 |
| September 28, 2026 | 27.45 |
| September 25, 2026 | 31.41 |
| September 24, 2026 | 32.85 |
| September 23, 2026 | 31.71 |
| September 22, 2026 | 30.90 |
| Date | Value |
|---|---|
| September 21, 2026 | 28.27 |
| September 18, 2026 | 37.05 |
| September 17, 2026 | 37.84 |
| September 16, 2026 | 34.17 |
| September 15, 2026 | 31.64 |
| September 14, 2026 | 30.55 |
| September 11, 2026 | 28.74 |
| September 10, 2026 | 28.00 |
| September 09, 2026 | 30.50 |
| September 08, 2026 | 30.00 |
| September 04, 2026 | 27.44 |
| September 03, 2026 | 27.67 |
| September 02, 2026 | 26.96 |
| September 01, 2026 | 28.44 |
| August 31, 2026 | 25.52 |
| August 28, 2026 | 27.88 |
| August 27, 2026 | 28.16 |
| August 26, 2026 | 28.85 |
| August 25, 2026 | 26.76 |
| August 24, 2026 | 23.18 |
| August 21, 2026 | 23.98 |
| August 20, 2026 | 24.61 |
| August 19, 2026 | 26.28 |
| August 18, 2026 | 25.70 |
| August 17, 2026 | 27.64 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.74 |
| Alnylam Pharmaceuticals, Inc. | 227.66 |
| Anika Therapeutics, Inc. | 21.27 |
| Savara, Inc. | 4.52 |
| Vericel Corp. | 43.04 |